Mutual FundsNews Novartis to acquire German Biotech MorphoSys for $2.9B, Expanding Cancer Drug Pipeline by admin 06/02/2024 06/02/2024 KEY TAKEAWAYS Novartis plans to acquire MorphoSys for $2.9 billion to expand its cancer treatment … 0 FacebookTwitterPinterestEmail
NewsStocks Sanofi To Acquire Inhibrx in $1.7 Billion Deal To Boost Rare Disease Drugs Pipeline by admin 23/01/2024 23/01/2024 KEY TAKEAWAYS Sanofi is buying Inhibrx in a $1.7 billion deal as the French pharmaceutical … 0 FacebookTwitterPinterestEmail
